IMP

IMP

@impvienna.bsky.social

The IMP is a leading life science centre in Europe with 220 researchers from 40 countries. Part of the ViennaBioCenter.

4K followers2.7K following293 posts

IMP reposted

🎉 Congratulations to our postdoc Tomas Pachano (Stark lab) on joining the FWF’s ESPRIT programme! With support from the FWF, Pachano will study how pathogens manipulate human cells and aims to build the first pan-pathogen functional atlas of effector activity: https://bit.ly/4jxyKbB

Sascha Amann won the 2026 Rabitsch Award! 🏆 A recent PhD graduate from the CryoEM Technology Platform, Amann received the award for his research on how the proteasome recognises and degrades proteins tagged with ubiquitin: https://bit.ly/4hQTCs1

Researchers from our Plaschka lab expected one molecular motor to dismantle the cell’s RNA-editing machine. Instead, they found three. Like three hands untying a knot, the motors act in sequence to take the spliceosome apart: https://bit.ly/4AQnqNQ

During Postdoc Appreciation Week, Vienna BioCenter postdocs hosted the Postdoc Networking Day—a lively day of new connections, shared ideas, and community at the IMP Lecture Hall.

She’s coming to the IMP, and she’s recruiting! 🔬 Doris Kaltenecker will join the IMP as a Group Leader in March 2027. Her lab will study organ-to-organ communication in systemic diseases, with a focus on cancer cachexia:

🎉 Congratulations to our Julia Bubis, postdoc at the Proteomics Technology Hub, on receiving the 2026 ÖGMBT Life Sciences Research Award Austria. Her award-winning workflow can quantify up to 5,300 proteins in a single cell: https://bit.ly/46nTZF9

View full thread
View full thread
View full thread

For nearly 40 years, Sanger sequencing has supported research at the IMP—from radioactive gels read by hand to automated systems processing hundreds of thousands of samples a year. As the service moves to an external provider, we look back at its remarkable journey: https://bit.ly/4cT44xi

IMP postdoc Elias Adriaenssens has received an ERC Starting Grant worth close to €1.5 million. He will study how cells decide when to dispose of their organelles—and how they prevent healthy ones from being destroyed: https://bit.ly/4zUBQMy

Tim Clausen’s lab at the IMP will participate in a Marie Skłodowska-Curie Doctoral Network to train early-career researchers and advance new ways to eliminate disease-causing proteins using the cell’s own degradation machinery:

🎉 Congratulations to our PhD student Sofia Moysiadou from the Obenauf lab on receiving a prestigious DOC Fellowship from the Austrian Academy of Sciences. Her project focuses on how lung cancer develops resistance to KRAS inhibitors:

Pathogens have spent millions of years learning how to hijack human cells. Now, researchers from the Stark lab at the IMP and the Taipale lab at the Donnelly Centre, University of Toronto, have built a platform to systematically discover how they do it:

View full thread

Pathogens have spent millions of years learning how to hijack human cells. Now, researchers from the Stark lab at the IMP and the Taipale lab at the Donnelly Centre, University of Toronto, have built a platform to systematically discover how they do it:

Thank you for attending the 20th Microsymposium on RNA Biology at the Vienna BioCenter! Three days of talks on small RNAs, from gene silencing to the role these molecules play in development, physiology, and disease.

The IMP is among Austria's leading contributors to exceptional life science research. In QED Science's new analysis of 57,455 bioRxiv preprints, Austria emerged as the strongest overperformer for its size. Of the 31 Austrian preprints in "The 1%", 11 include the IMP:

From the Vienna BioCenter to Max Planck: Fränze Müller is launching her own Proteomics Lab in Potsdam. We spoke with her about the move, the future of proteomics, and the kind of lab culture she hopes to build:

How do cells keep powerful antiviral responses under control—while staying ready to activate them within moments of infection? Researchers from Moritz Gaidt's lab at the IMP discovered that repetitive DNA can act as a powerful immune switch: